Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: PRIVO TECHNOLOGIES, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-09-15 to 2024-09-14
Current total value of award: $2049944
Description: TOPIC TITLE: CANCER TREATMENT TECHNOLOGIES FOR LOW-RESOURCE SETTINGS PROJECT TITLE: PRV311: A STANDALONE, SAFE, EFFECTIVE, AND AFFORDABLE TREATMENT FOR EARLY-STAGE CERVICAL CANCER IN LMICS